CSL Limited retain rights to clazakizumab in end-stage kidney disease. Eli Lilly gets rights to the the IL-6-blocking antibody in other indications that could put it in competition with Novo Nordisk and Novartis. The post Eli Lilly Joins Chase for Hot Inflammation Target, Paying $100M for Rights to CSL Drug appeared first on MedCity News.
[Sponsored] Healthcare executives spoke with MedCity News on how their businesses are using tech to shape the clinician and patient experience. The post How to Build Effective Referral Networks and Improve Patient Navigation [Video] appeared first on MedCity News.
This chart collection compares health care spending in the U.S. and other industrialized countries, including data on health spending per person and the growth rate in recent years and over time.
Verdiva Bio’s once-a-week oral GLP-1 drug is ready for Phase 2 testing. The drug, made with a proprietary technology that enables oral dosing, was licensed from Sciwind Biosciences. The post Metabolic Meds Startup Verdiva Launches With $410M and a Weekly Oral GLP-1 Drug appeared first on MedCity News.
This brief provides an explanation of Title 42 and its application in border regions, the impact of Title 42 on border expulsions and the health and well-being of migrants during COVID-19, and a discussion of the potential implications of reinvoking Title 42 restrictions for immigration and the health of migrants.
This year’s HIMSS conference featured many news announcements — from advanced partnerships to product launches to new research. In this list, MedCity News compiled short summaries for six of the conference’s most notable announcements. The post 6 HIMSS Announcements You Don’t Want to Miss appeared first on MedCity News.
Technology has the power to revolutionize treatment, make it more widely available, provide additional patient insight, and ultimately, alleviate the strain on our already stressed healthcare system. The post Community-Driven Digital Solutions Can Transform Addiction Treatment and Ease the Burden on the Healthcare System appeared first on MedCity News.
UCSF’s Lisa Rotenstein, M.D., M.B.A., discusses a Health Affairs Commentary article about the relationship between physicians, advanced practice providers in primary care
Two executives at behavioral health care companies discussed why it’s important for provider organizations to partner with the 988 Suicide & Crisis Lifeline during a panel at the Behavioral Health Tech conference. The post There’s an Opportunity for More Providers to Partner with the 988 Lifeline, Execs Say appeared first on MedCity News.
How does a hospital’s participation in a health plan’s Medicare Advantage (MA) provider network impact their commercial rates? Since many insurers offer both MA plans and commercial plans, there could be spillovers with respect to negotiating. How would MA network participation impact commercial rates? Marr et al. (2025) offers some hypotheses: On the one hand,…